Log in

NASDAQ:OBLNObalon Therapeutics Earnings Date, Estimates & History

-0.01 (-1.87 %)
(As of 08/13/2020 04:00 PM ET)
Today's Range
Now: $0.77
50-Day Range
MA: $0.72
52-Week Range
Now: $0.77
Volume98,500 shs
Average Volume433,126 shs
Market Capitalization$5.95 million
P/E RatioN/A
Dividend YieldN/A


Obalon Therapeutics (NASDAQ:OBLN) Earnings Information

Obalon Therapeutics last posted its earnings results on July 30th, 2020. The reported ($0.54) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.24. The business had revenue of $0.70 million for the quarter. Obalon Therapeutics has generated $0.00 earnings per share over the last year. Obalon Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 13th, 2020 based off prior year's report dates.

Obalon Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Obalon Therapeutics (NASDAQ OBLN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
7/30/20206/30/2020($0.30)($0.54)($0.54)$0.70 millionN/A
6/19/20203/31/2020($0.51)($0.68)($0.68)$0.78 millionN/A
2/27/202012/31/2019($0.58)($0.64)($0.64)$0.79 millionTranscript
11/8/20199/30/2019($3.50)($0.61)($0.61)$2.20 million$0.33 millionTranscript
7/24/2019Q2($0.27)($0.25)($0.25)$1.82 million$0.39 millionN/A
5/10/2019Q1 2019($3.60)($3.60)($0.36)$1.74 million$1.78 millionN/A
2/22/201912/31/2018($3.10)($3.90)($0.39)$2.10 million$2.04 millionN/A
11/2/20189/30/2018($4.60)($3.50)($0.35)$2.45 million$2.99 millionN/A
8/2/2018Q2($5.10)($5.70)$0.57$3.40 million$2.73 millionN/A
5/10/2018Q1 2018($5.40)($7.10)($0.71)$3.55 million$1.35 millionN/A
3/5/2018Q4 2017($4.80)($6.00)($0.60)$3.88 million$3.69 millionTranscript
11/3/2017Q3 2017($4.30)($5.50)($0.55)$2.95 million$2.79 millionN/A
8/2/2017Q2 2017($4.30)($4.60)($0.46)$1.77 million$1.96 millionListen
5/10/2017Q1 2017($3.30)($4.70)($0.47)$1.60 million$1.47 millionN/A
2/23/2017Q4 2016($3.30)($5.10)($0.51)$0.70 million$0.77 millionN/A
11/11/2016Q3 2016($3.20)($54.60)($5.46)$0.70 million$0.77 millionListen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.